Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
MoonLake Immunotherapeutics AG
Assistance Publique - Hôpitaux de Paris
Brain Inflammation Collaborative